SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Acacia (ACRI)--a stock for the future
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Lee who wrote ()7/13/1999 7:06:00 AM
From: Paul Lee   of 1135
 
Acacia Research Subsidiary Presents New Biochip Technology at American Peptide Symposium

PASADENA, Calif.--(BUSINESS WIRE)--July 13, 1999--Acacia Research Corp. (Nasdaq/NM:ACRI) Tuesday reported that its subsidiary CombiMatrix Corp. presented information at the 16th Annual American Peptide Symposium held in Minneapolis demonstrating the company's ability to synthesize peptides on its proprietary biochip.

The CombiMatrix biochip system integrates the miniaturization of semiconductors with new developments in biotechnology and chemistry. The company's core technology utilizes a unique buffering system to create "virtual reactors" -- tiny chemical flasks the size of a human hair, that are separated from each other without glass walls.

The CombiMatrix technology synthesizes DNA, peptides and other chemicals in these miniaturized electrochemical flasks on a tiny semiconductor chip.

The biochips are inexpensively produced on existing semiconductor fabrication lines. This eliminates the need for expensive photomasks or robots at CombiMatrix, and reduces the investment in capital equipment and clean rooms at the company. CombiMatrix's unique biochip system may offer significant advantages over current products on the market.

Acacia Research has a 53 percent equity ownership in CombiMatrix, which is located in Burlingame, Calif.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News